Viking Therapeutics Inc (VKTX)

Viking Therapeutics Inc (VKTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.1B; returns 1 day -5.5%, 1 week -3.1%, 1 year -28.1%.

Viking Therapeutics, Inc. (VKTX) is a clinical-stage biopharmaceutical company developing therapies for metabolic and endocrine disorders, with no approved products or significant revenue streams. The company funds its operations through equity financings and cash reserves, reporting minimal revenue primarily from grants or interest.

Groups VKTX belongs to

• Clinical Stage Biopharma
• Biotechnology
• Metabolic Disorders
• GLP-1 Agonists
• Clinical Stage
• Weight Management
• NASH
• Healthcare
• Pharmaceuticals
• Endocrinology
• Liver Disease
• Life Sciences

VKTX financial model: income statement, cash flow and balance sheet